News Conference News AHA 2023 DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI Shelley Wood November 11, 2023
News Conference News AHA 2022 Cangrelor After Ticagrelor Pretreatment in ACS Might Be OK: SWAP-5 Yael L. Maxwell November 11, 2022
News Conference News AHA 2022 BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI Shelley Wood November 06, 2022
News Conference News AHA 2020 When PCI Decisions Ignore FFR Results, Patients Pay a Price Caitlin E. Cox November 14, 2020
News Conference News AHA 2019 Complete Revascularization Benefits May Be Due to Stenting Vulnerable Plaques Todd Neale November 21, 2019
News Conference News AHA 2019 More Adverse Events, Higher Costs With Impella: New Observational Studies Caitlin E. Cox November 17, 2019
News Conference News AHA 2018 Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI Todd Neale November 11, 2018
News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018
News Conference News AHA 2017 Survey Says: Interventionalists Believe Public Reporting Leads to High-Risk PCI Avoidance, Upcoding Yael L. Maxwell November 15, 2017
News Conference News AHA 2016 PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests Yael L. Maxwell November 16, 2016
News Conference News ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients November 13, 2011